| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 104819-42-3 | 3-[6-(4-Bromophenyl)Imidazo[2,1-b][1,3]Thiazol-3-Yl]-6-Chloro-2,7-Dimethylchromen-4-One | C22H14BrClN2O2S |
| 104819-48-9 | 2-Bromo-3-Methoxy-Pyridine 1-Oxide | C6H6BrNO2 |
| 104819-52-5 | 2-Bromo-3,4-dimethoxypyridine | C7H8BrNO2 |
| 104820-55-5 | 1-(4-Azidophenyl)-8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-Methyl-1,3,8-Triazaspiro[4.5]Decan-4-One | C24H27FN6O2 |
| 104820-74-8 | 16alpha-Iodo-11beta-Methoxy-17beta-Estradiol | C19H25IO3 |
| 104820-88-4 | 6-[(Hydroxysulfanyl)Carbonyl]-2-Pyridinecarboxylic Acid | C7H5NO4S |
| 104820-97-5 | 8''-Hydroxypactamycin | C28H38N4O9 |
| 104821-25-2 | Dihydroethidium | C21H21N3 |
| 104821-32-1 | Bicyclo[2.2.1]heptan-2-yl dimethoxy-(methyl)silane | C10H20O2Si |
| 104821-37-6 | Cloflumide | C22H27ClFN3O4S2 |
| 104821-45-6 | 4-(2-chloro-10,11-dihydro-7-fluorodibenzo(b,f)thiepin-10-yl)-N-hydroxy-1-Piperazinepropanimidamide (Z)-2-butenedioate hydrate (2:4:1) | C29H32ClFN4O9S |
| 104825-21-0 | 3-(Cyanomethyl)-4-Nitrobenzoic Acid | C9H6N2O4 |
| 104825-24-3 | 4-(Cyanomethyl)-3-Nitrobenzoic Acid | C9H6N2O4 |
| 104825-25-4 | 2-(Cyanomethyl)-5-Nitrobenzoic Acid | C9H6N2O4 |
| 104825-33-4 | 5-(Cyanomethyl)-2-Nitrobenzoic Acid | C9H6N2O4 |
| 104825-34-5 | 3-(Cyanomethyl)-2-Nitrobenzoic Acid | C9H6N2O4 |
| 104826-49-5 | [(2R,3S,4R,5S)-5-(4-Aminophenoxy)-4-Hydroxy-2-[[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentoxy]Methyl]Oxolan-3-Yl] Dihydrogen Phosphate | C16H26NO12P |
| 104828-93-5 | 2-(Phenylselanyl)-2-Propen-1-Ol | C9H10OSe |
| 104829-98-3 | 3-Amino-2-bromo-4,6-dimethylpyridine | C7H9BrN2 |
| 104830-01-5 | Ethyl (2E)-3-(2-Amino-3-Pyridinyl)Acrylate | C10H12N2O2 |
| 104830-06-0 | 3-Iodopyridin-2-amine | C5H5IN2 |
| 104830-07-1 | Ethyl (2E)-3-(2-Amino-3-Pyridinyl)Acrylate | C10H12N2O2 |
| 104830-08-2 | Ethyl (E)-3-(2-Chloropyridin-3-Yl)Prop-2-Enoate | C10H10ClNO2 |
| 104830-09-3 | 2-Bromo-3-Iodo-4,6-Dimethylpyridine | C7H7BrIN |
| 104830-21-9 | (1Z)-1-[(4-Methylphenyl)Imino]-1H-Isoindol-3-Amine | C15H13N3 |
| 104830-22-0 | (1Z)-1-[(4-Methoxyphenyl)Imino]-1H-Isoindol-3-Amine | C15H13N3O |
| 104831-94-9 | (3R)-1-Benzyl-3-Pyrrolidinyl Methyl 2,6-Dimethyl-4-(3-Nitrophenyl)-1,4-Dihydro-3,5-Pyridinedicarboxylate Hydrochloride (1:1) | C27H30ClN3O6 |
| 104833-43-4 | 1-Amino-1-deoxy-D-glucitol hydrochloride | C6H15NO5.HCl |
| 104834-93-7 | 1-[(Dimethylamino)Methyl]-1,3-Dihydro-2-Benzofuran-4,5-Diol | C11H15NO3 |
| 104835-70-3 | 5'-O-[(R)-Hydroxy(Phosphonomethyl)Phosphoryl]Adenosine | C11H17N5O9P2 |
| 104837-20-9 | 6-(Benzoyl)-3-[(4-Phenylpiperidin-1-Yl)Methyl]-1,3-Benzoxazol-2-One | C26H24N2O3 |
| 104838-12-2 | N-[2-[4-[(Acetylamino)sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide | C16H18N4O4S |
| 104839-00-1 | N-[(1,1-Dimethylethoxy)Carbonyl]-O-Ethyl-L-Serine | C10H19NO5 |
| 104839-39-6 | 10,11-Dihydroxy-5H-dibenz[b,f]azepine-5-carboxamide | C15H12N2O3 |
| 104840-15-5 | N-(6-Methyldipyrido(1,2-A:3',2'-D)Imidazol-2-Yl)Acetamide | C13H12N4O |
| 104840-34-8 | (2S,3S,4S,5R,6R)-N-[3-(4-Aminobutylamino)Propyl]-6-(4-Amino-2-Oxopyrimidin-1-Yl)-3-[[(2R)-3-(Diaminomethylideneamino)-2-[(2-Methylaminoacetyl)Amino]Propanoyl]Amino]-4,5-Dihydroxyoxane-2-Carboxamide | C24H44N12O7 |
| 104840-35-9 | (2S,3S,4S,5R,6R)-6-(4-Amino-2-Oxopyrimidin-1-Yl)-3-[[(2R)-3-(Diaminomethylideneamino)-2-[(2-Methylaminoacetyl)Amino]Propanoyl]Amino]-4,5-Dihydroxyoxane-2-Carboxamide | C17H28N10O7 |
| 104840-48-4 | 4-(3-Methyl-3-Buten-1-Yl)Morpholine | C9H17NO |
| 104842-16-2 | (8S,9S,11S,13S,14S,16R,17R)-16-Iodo-11-Methoxy-13-Methyl-6,7,8,9,11,12,14,15,16,17-Decahydrocyclopenta[a]Phenanthrene-3,17-Diol | C19H25IO3 |
| 104842-73-1 | 2-(1-Piperazinyl)Nicotinaldehyde | C10H13N3O |
| 104845-82-1 | O,O'-1,3-Propanediylbishydroxylamine dihydrochloride | C3H10N2O2.2(HCl) |
| 104846-62-0 | (3S,5Z,7E,14xi,22E)-3-{[Dimethyl(2-Methyl-2-Propanyl)Silyl]Oxy}-9,10-Secoergosta-5,7,10,22-Tetraene | C34H58OSi |
| 104846-63-1 | (1,1-Dimethylethyl)[(3beta,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-yloxy]dimethylsilane | C34H58OSi |
| 104847-07-6 | N-tert-Butyl-2-methylbenzamide | C12H17NO |
| 104849-33-4 | (8S,9S,10R,13S,14S,17S)-17-(3-Ethoxyprop-2-Ynoyl)-10,13-Dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-Dodecahydrocyclopenta[a]Phenanthren-3-One | C24H32O3 |
| 104849-39-0 | (4bS,7S,8aS)-7-[(1R)-1-Hydroxyprop-2-Ynyl]-7-Methyl-5,6,8,8a,9,10-Hexahydro-4bH-Phenanthren-2-Ol | C18H22O2 |
| 104851-39-0 | 5-Isopropylindane | C12H16 |
| 104852-44-0 | alpha,alpha-Dimethylbenzenemethanol C6-8-neocarboxylperoxoate | |
| 104855-13-2 | 9-Iodooctadecanoic Acid | C18H35IO2 |
| 104855-14-3 | 10-Iodooctadecanoic Acid | C18H35IO2 |